Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 1/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.44 |
| ▸ | CA1 | P00915 | 4/20 | 0.42 |
| ▸ | CA2 | P00918 | 4/20 | 0.42 |
| ▸ | CA7 | P43166 | 1/20 | 0.42 |
| ▸ | CA9 | Q16790 | 1/20 | 0.42 |
| ▸ | ACHE | P22303 | 1/20 | 0.42 |
| ▸ | ESR1 | P03372 | 2/20 | 0.39 |
| ▸ | ESR2 | Q92731 | 2/20 | 0.39 |
| ▸ | IDO1 | P14902 | 1/20 | 0.36 |
| ▸ | ORAI1 | Q96D31 | 1/20 | 0.36 |
| ▸ | ORAI2 | Q96SN7 | 1/20 | 0.36 |
| ▸ | ORAI3 | Q9BRQ5 | 1/20 | 0.36 |
| ▸ | TRPV6 | Q9H1D0 | 1/20 | 0.36 |
| ▸ | CES2 | O00748 | 1/20 | 0.36 |
| ▸ | CES1 | P23141 | 1/20 | 0.36 |
| ▸ | LOXL2 | Q9Y4K0 | 1/20 | 0.36 |
| ▸ | MMP1 | P03956 | 1/20 | 0.35 |
| ▸ | MMP2 | P08253 | 1/20 | 0.35 |
| ▸ | MMP9 | P14780 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Bromide SCHEMBL28417395 | 0.97 | CYP3A4 (0.42) | CYP3A4TDP1CA1CA2CA7 | |
| SCHEMBL5713320 | 0.97 | CYP3A4 (0.42) | CYP3A4TDP1CA1CA2CA7 | |
| Hydrochloric Acid SCHEMBL21724713 | 0.94 | CYP3A4 (0.40) | CYP3A4TDP1CA1CA2CA7 | |
| SCHEMBL2543676 | 0.88 | CYP3A4 (0.67) | CYP3A4TDP1CA1CA2CA7 | |
| SCHEMBL8530919 | 0.88 | CYP3A4 (0.36) | CYP3A4TDP1CA1CA2CA7 | |
| SCHEMBL10874458 | 0.88 | CYP3A4 (0.67) | CYP3A4TDP1CA1CA2CA7 | |
| SCHEMBL18702923 | 0.88 | CYP3A4 (0.67) | CYP3A4TDP1CA1CA2CA7 | |
| SCHEMBL31328588 | 0.88 | CYP3A4 (0.36) | CYP3A4TDP1CA1CA2CA7 | |
| SCHEMBL17563446 | 0.86 | ACHE (0.68) | TDP1ACHENFE2L2 | |
| SCHEMBL14422408 | 0.84 | NFE2L2 (0.58) | NFE2L2FBP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1523 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122076491-A | Preparation of supported copper alloy nanocluster catalyst and application of supported copper alloy nanocluster catalyst in photocatalytic degradation | — | 2026-05-26 | — | — | CN | claimed |
| CN-122059813-A | Synthesis method of 1, 1-diaryl ethylene | 南通大学 | 2026-05-19 | — | — | CN | claimed |
| CN-119371356-B | Nuciferine derivative, and preparation method and application thereof | 云南中医药大学 | 2026-05-19 | — | — | CN | claimed |
| US-20260128365-A1 | POSITIVE ELECTRODE SLURRY FOR ALL-SOLID-STATE BATTERY AND METHOD FOR PRODUCING SAME, ALL-SOLID-STATE BATTERY PRODUCED USING SAME | SAMSUNG SDI CO LTD (KR) | 2026-05-07 | — | — | US | claimed |
| EP-4738511-A1 | POSITIVE ELECTRODE SLURRY FOR ALL-SOLID-STATE BATTERY AND METHOD FOR PRODUCING SAME, ALL-SOLID-STATE BATTERY PRODUCED USING SAME | SAMSUNG SDI CO., LTD. (KR) | 2026-05-06 | — | — | EP | claimed |
| US-20260109691-A1 | PROCESS FOR MANUFACTURING ALOGABAT | HOFFMANN-LA ROCHE INC. (US) | 2026-04-23 | — | — | US | claimed |
| CN-120118068-A | Chemical process for preparing phenylpiperidinyl indole derivatives | 诺华股份有限公司 | 2025-06-10 | — | — | CN | claimed |
| CN-120092001-A | Method for producing ALOGABAT | 豪夫迈·罗氏有限公司 | 2025-06-03 | — | — | CN | claimed |
| CN-120081808-A | Low-cost synthesis method of furan acetate compound | 中国科学院兰州化学物理研究所 | 2025-06-03 | — | — | CN | claimed |
| CN-120040393-A | Method for synthesizing furfuryl acetate compounds by carbonyl synthesis of furfuryl alcohol and derivatives | 中国科学院兰州化学物理研究所 | 2025-05-27 | — | — | CN | claimed |
| WO-1998025135-A1 | ELECTROPHORESIS SEPARATION METHODS | MACQUARIE RESEARCH LTD. (AU) | 1998-06-11 | — | — | WO | claimed |
| US-5693832-A | Hydroformylation of allyl alcohol | SHOWA DENKO K.K (JP) | 1997-12-02 | — | — | US | claimed |
| EP-0489330-B1 | Sulphonated tris(p-fluorophenyl)phosphane | HOECHST AG (DE) | 1995-08-16 | — | — | EP | claimed |
| EP-0489330-A1 | Sulphonated tris(p-fluorophenyl)phosphane | HOECHST AKTIENGESELLSCHAFT (DE) | 1992-06-10 | — | — | EP | claimed |
| US-4824817-A | Catalyst for the carbonylation of conjugated dienes | SHELL OIL COMPANY (US) | 1989-04-25 | — | — | US | claimed |
| EP-0132840-B1 | ETHYLENE DIMERIZATION | PHILLIPS PETROLEUM COMPANY (US) | 1987-11-11 | — | — | EP | claimed |
| US-4575562-A | CARBONYLATION, ESTERIFICATION, QUINONE OXIDANT, HYDROGENATION | MONSANTO COMPANY (US) | 1986-03-11 | — | — | US | claimed |
| US-4528415-A | Ethylene dimerization | PHILLIPS PETROLEUM COMPANY (US) | 1985-07-09 | — | — | US | claimed |
| EP-0132840-A2 | Ethylene dimerization | PHILLIPS PETROLEUM COMPANY (US) | 1985-02-13 | — | — | EP | claimed |
| US-4487847-A | COORDINATION CATALYST, NICKEL-PHOSPHINE COMPOLENTS | PHILLIPS PETROLEUM COMPANY (US) | 1984-12-11 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260109691-A1 | PROCESS FOR MANUFACTURING ALOGABAT | GABRA5, GABRA1, GABRA2 | CYP3A4 834/4885TDP1 2944/4885CA1 3912/4885 |
| US-20260128365-A1 | POSITIVE ELECTRODE SLURRY FOR ALL-SOLID-STATE BATTERY AND METHOD FOR PRODUCING SAME, ALL-SOLID-STATE BATTERY PRODUCED USING SAME | TST, SLC6A12, NCS1 | CYP3A4 3727/4885TDP1 694/4885CA1 225/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.